Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bengaluru
Clinical trial register · India

Clinical Trials in Bengaluru, 2026

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1120 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:16 UTC
1120
Studies in scope
all four open statuses
608
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
New Delhi 339 Mumbai 260 Hyderabad 233 Bangalore 199 Pune 186
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Bristol-Myers Squibb9 AstraZeneca9 Novo Nordisk A/S6 University of Pittsburgh5 Janssen Research & Development, LLC5
Site location
New Delhi339 Mumbai260 Hyderabad233 Bangalore199 Pune186
All 274 locations
Target enrolment
to

Trials with a site in Bengaluru

87 of 1120 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
Efficacy of Sleep Hygiene Intervention in Elderly With Insomnia
NCT06652789Eelderly With Sleep Disturbances
University of Pittsburgh
Not applicable
100
Bengaluru
2027-02
Recruiting
Astellas Pharma Inc
Phase 3
100
Bengaluru
2026-10-23
Not yet open
Eli Lilly and Company
Phase 4
30
Ahmedabad, Bengaluru, Bhubaneswar, Hisar, Kolkata, Kozhikode, Mumbai (E), New Delhi
2026-10
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bengaluru, Gūrgaon, Jaipur, Kolkata, New Delhi, Pune
2026-05-31
Not yet open
Novo Nordisk A/S
Phase 3
1,000
Guntur, Surat, Vadodara, Bangalore, Bengaluru, Kochi, Indore, Mumbai
2026-05-20
Recruiting
Novo Nordisk A/S
Phase 3
300
Guntur, Vijayawada, Bengaluru, Kochi, Mumbai, Nagpur, New Delhi, Delhi
2026-05-05
Recruiting
Novo Nordisk A/S
Phase 3
300
Guntur, Vijayawada, Bengaluru, Kochi, Mumbai, Nagpur, Delhi, Bhubaneswar
2026-05-05
Recruiting
JCR Pharmaceuticals Co., Ltd.
Observational
57
Bengaluru
2026-03-25
Active, closed
Eli Lilly and Company
Phase 4
344
Ahmedabad, Ajmer, Allahabād, Bengaluru, Bhubaneswar, Chennai, Coimbatore, Guwahati
2026-02-27
Recruiting
Eli Lilly and Company
Phase 3
800
Bengaluru, Bhubaneswar, Guntur, Nagpur, New Delhi, Pune, Raipur, Rishikesh
2026-02-10
Recruiting
Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NCT07209917Cervical Cancer, Human Papillomavirus (HPV) Infection, Human Immunodeficiency Virus (HIV) Infection
University of California, Irvine
Not applicable
348
Bangalore, Bengaluru
2026-02-01
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Bangalore, Bengaluru, Mumbai, Nashik, New Delhi, Varanasi, Hyderabad
2026-01-02
Recruiting
Sanofi
Phase 3
85
Bengaluru, Mumbai, Pune, Vellore
2025-12-18
Recruiting
Bristol-Myers Squibb
Phase 2/3
500
Ahmedabad, Gurugram, Bengaluru, Mumbai, Nagpur, New Delhi, Howrah
2025-11-05
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Bangalore, Bengaluru, Bhubaneswar, Gurugram, Hyderabad, Jaipur, Kochi, Ludhiana
2025-10-03
Active, closed
Janssen Research & Development, LLC
Phase 3
896
Bangalore, Bengaluru, Bhubaneswar, Ernākulam, Gurugram, Hyderabad, Jaipur, Ludhiana
2025-10-01
Recruiting
Pfizer
Phase 3
400
Surat, Gurugram, Bengaluru, Mumbai, Nashik, Pune, Thane, Bhubaneswar
2025-08-05
Active, closed
Sanofi
Phase 4
110
Bengaluru, Jaipur, Kolkata, Nagpur, New Delhi, Pune, Vizianagaram
2025-07-31
Not yet open
SafeBoosC-IIIv - Does Cerebral Oximetry Monitoring Affect Renal Outcomes
NCT06926946Acute Renal Failure, Neonatal Morbidity
St. John's Research Institute
Not applicable
1,000
Bengaluru
2025-07-31
Recruiting
Celgene
Phase 3
400
Bengaluru, Mumbai, New Delhi, Hyderabad
2025-07-28
Recruiting
AbbVie
Phase 4
100
Gurgaon, Bengaluru, Thiruvananthapuram, Mumbai, Pune, New Delhi, Bhubaneswar, Chennai
2025-07-24
Recruiting
Pfizer
Phase 3
714
Bengaluru, Mumbai, Pune, Thane, New Delhi, Hyderabad
2025-07-23
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Ahmedabad, Bengaluru, Bikaner, Kanpur, Kolkata, Maharashtra, Nagpur, Nashik
2025-07-22
Recruiting
Bristol-Myers Squibb
Phase 3
586
Bengaluru, Hyderabad, Varanasi, Kolkata
2025-07-14
Recruiting
Novartis Pharmaceuticals
Phase 3
940
Gurgaon, Bengaluru, Mumbai
2025-07-01
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Ajmer, Bengaluru, Kolkata, Lucknow, Nashik, Rohtak, Visakhapatnam
2025-06-09
Recruiting
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates
NCT06377397Sepsis, PROM, Preterm (Pregnancy), Early-Onset Neonatal Sepsis, Preterm Premature Rupture of Membrane
Indian Council of Medical Research
Phase 3
1,500
Chandigarh, Rohtak, Bengaluru, Chhatrapati Sambhajinagar, Mumbai, New Delhi, Chennai, Lucknow
2025-06-07
Active, closed
Johnson & Johnson Private Limited
Phase 4
75
Bangalore, Bengaluru, Chandigarh, Jaipur, Kolkata, Mumbai, Nagpur, New Delhi
2025-05-22
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
8,000
Bengaluru, Chennai, Lucknow, Vellore
2025-03-01
Recruiting
Bristol-Myers Squibb
Phase 3
530
Bengaluru, New Delhi, Madurai, Varanasi, Kolkata
2025-02-25
Recruiting
Pfizer
Observational
50
Bengaluru, Chennai, Coimbatore, Madurai
2025-01-30
Recruiting
Novo Nordisk A/S
Phase 2
465
Guntur, Bengaluru, Kozhikode, Jaipur, Hyderabad
2024-12-02
Recruiting
University of Pittsburgh
Not applicable
96
Bengaluru
2024-11-01
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Badsa, Bengaluru, Thiruvananthapuram, Mumbai, New Delhi, Secunderabad, Varanasi, Howrah
2024-10-07
Recruiting
Pfizer
Phase 2
48
Surat, Bengaluru, Pune, Lucknow, Kolkata
2024-09-25
Recruiting
University of Pittsburgh
Not applicable
168
Bengaluru, Bhubaneswar
2024-08-31
Recruiting
Krishnadevaraya College of Dental Sciences & Hospital
Phase 1
36
Bengaluru
2024-07-01
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Guntur, Visakhapatnam, Raipur, Ahmedabad, Surat, Vadodara, Bengaluru, Mangaluru
2024-06-25
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bangalore, Bengaluru, Bikaner, Chennai, Chhatrapati Sambhajinagar, Guwahati, Gūrgaon, Kochi
2024-06-17
Active, closed
University of Pittsburgh
Not applicable
104
Bengaluru
2024-06-15
Recruiting
University of Pittsburgh
Not applicable
32
Bengaluru
2024-05-17
Recruiting
Institute of Liver and Biliary Sciences, India
Observational
250
Guindy, Ahmedabad, Surat, Srinagar, Bengaluru, Mangalore, Kochi, Thiruvananthapuram
2024-05-02
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Bengaluru, Chandigarh, Delhi, Gūrgaon, Mangaluru, Nagpur, New Delhi, Thiruvananthapuram
2024-04-16
Active, closed
Novo Nordisk A/S
Phase 3
673
Vijayawada, Visakhapatnam, Vadodara, Belagavi, Bengaluru, Mysuru, Udupi, Nagpur
2024-04-01
Recruiting
GlaxoSmithKline
Phase 3
864
Mumbai, Pune, Bengaluru, Bhubaneswar, Gūrgaon, Hyderabad, Nashik, Nehru Nagar Belagavi Karnataka 590010
2024-03-21
Active, closed
Sanofi
Phase 3
943
Bengaluru, Hyderabad, New Delhi, Shimla
2023-12-27
Active, closed
Bristol-Myers Squibb
Phase 3
190
Ahmedabad, Gurugram, Bengaluru, Pune, New Delhi
2023-12-21
Recruiting
Eli Lilly and Company
Phase 3
1,264
Ahmedabad, Belagavi, Bengaluru, Bhubaneswar, Coimbatore, Hyderabad, Karad, Kolhāpur
2023-12-21
Recruiting
AstraZeneca
Phase 3
1,145
Bengaluru, Hyderabad, Jaipur, Kanpur, Kochi, Kolkata, Lucknow, Madurai
2023-12-14
Recruiting
Octapharma
Phase 4
28
Vellore, Bengaluru
2023-11-28
Active, closed
AstraZeneca
Phase 3
1,902
Bengaluru, Delhi, Kolkata, Marg Jaipur, Nagpur, Nashik, Thiruvananthapuram, Vadodara
2023-11-14
Active, closed
AstraZeneca
Phase 3
895
Bengaluru, Hyderabad, Kolkata, Mysuru, Nagpur, Varanasi
2023-10-24
Active, closed
Bristol-Myers Squibb
Phase 3
402
Ahmedabad, Bengaluru, New Delhi, Bhubaneswar
2023-10-24
Recruiting
GlaxoSmithKline
Phase 3
892
Bengaluru, Ludhiana, Belagavi, Hyderabad, Nashik, Pune
2023-08-01
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Hyderabad, Chandigarh, Faridabad, Bengaluru, Trivandrum, Jaipur, Vellore, Lucknow
2023-07-06
Active, closed
Alumis Inc
Phase 2
408
New Delhi, Ahmedabad, Bangalore, Bengaluru, Chandigarh, Haryāna, Jaipur, Lucknow
2023-06-26
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Aligarh, Amritsar, Bangalore, Belagavi, Bengaluru, Bikaner, Chennai, Chhatrapati Sambhajinagar
2023-04-11
Active, closed
Sanofi
Phase 2
999
Bengaluru, Bikaner, Kochi, Kolkata, Mangaluru, Nashik, Surat
2023-04-03
Active, closed
Bristol-Myers Squibb
Phase 3
516
Vizianagaram, Ahmedabad, Surat, Gurugram, Bengaluru, Hyderabad
2023-01-12
Active, closed
Bristol-Myers Squibb
Phase 3
606
Gurgaon, Bengaluru, Mumbai, Thane, New Delhi, Mohali, Chennai, Hyderabad
2023-01-10
By invitation
Tolmar Inc.
Phase 3
250
Surat, Bangalore, Bengaluru, Mysore, Nagpur, Pune, Erode, Varanasi
2022-12-28
Recruiting
Bayer
Phase 3
100
Ahmedabad, Bengaluru, Delhi, Kolkata
2022-11-08
Recruiting
Bayer
Phase 4
50
Nadiād, Bengaluru, Kochi, Thiruvananthapuram, Vellalasseri, Amravati, Mumbai, New Delhi
2022-08-03
Recruiting
CHA University
Not applicable
240
Bengaluru
2022-08-01
Active, closed
PureTech
Phase 2
240
Vadodara, Bengaluru, Chhatrapati Sambhajinagar, Nagpur, Hyderabad, Kanpur, Kolkata, Belagāve
2022-07-22
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Ahmedabad, Bengaluru, Bhubaneswar, Chennai, Gūrgaon, Hyderabad, Mumbai, New Delhi
2022-07-22
Active, closed
Glenmark Specialty S.A.
Phase 1
320
Vijayawada, Visakhapatnam, Gurgaon, Bangalore, Bengaluru, Kannur, Chhatrapati Sambhajinagar, Mumbai
2022-06-28
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Hyderabad, Ahmedabad, Nadiād, Bengaluru, Manipal, Kozhikode, Thiruvananthapuram, Pune
2022-04-05
Active, closed
Bayer
Phase 3
219
Ahmedabad, Bengaluru, Delhi, Kolkata
2022-03-28
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Ahmedabad, Nadiād, Bengaluru, Manipal, Kozhikode, Thiruvananthapuram, Chhatrapati Sambhajinagar, Pune
2022-03-15
Active, closed
Lorlatinib Continuation Study
NCT05144997Non-Small-Cell Lung Cancer, NSCLC
DrugLorlatinib
Pfizer
Phase 4
76
Bengaluru, Thane
2021-12-28
Active, closed
Beeline Medicines Corporation
Phase 2
248
Ahmedabad, Gurugram, Bengaluru, New Delhi, Secunderabad
2021-10-11
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
European Foundation for Study of Chronic Liver Failure
Observational
3,000
Bengaluru, Mumbai, New Delhi, Jaipur, Chennai, Gurugramam, Kochi, Secunderabad
2021-07-08
Active, closed
Tolmar Inc.
Phase 3
250
Vijayawada, Visakhapatnam, Ahmedabad, Surat, Bengaluru, Mysore, Nagpur, Nashik
2021-07-01
Active, closed
AstraZeneca
Phase 3
1,157
Ahmedabad, Bangalore, Bengaluru, Calicut, Gūrgaon, Mysuru, Nashik, New Delhi
2021-04-26
Active, closed
Geron Corporation
Phase 3
327
Surat, Bangalore, Bengaluru, New Delhi, Gūrgaon, Bhubaneswar, Kolkata, Pune
2021-04-12
Recruiting
Epygenix
Phase 3
150
Hyderabad, Surat, Belagavi, Bengaluru, Kochi, Pune, Mumbai, Nagpur
2020-09-15
Active, closed
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma
DrugsOregovomab·Paraplatin·Taxol·Paclitaxel
CanariaBio Inc.
Phase 3
615
Bangalore, Bengaluru, Delhi, Mohali, Mumbai, Noida, Pune
2020-08-25
Active, closed
AstraZeneca
Phase 3
866
Bengaluru, Calicut, Kolkata, Marg Jaipur, New Delhi, Surat, Thiruvananthapuram
2020-07-24
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
160
Ahmedabad, Bengaluru, Hyderabad, Madurai, New Delhi, Pune, Vellore
2020-07-13
Active, closed
AstraZeneca
Phase 3
587
Belagavi, Bengaluru, Gūrgaon, Kolkata, New Delhi, Pune
2019-07-02
Active, closed
AstraZeneca
Phase 3
724
Bangalore, Bengaluru, Hyderabad, Kolkata, Madurai, Mumbai, Nashik, Pune
2018-11-30
Active, closed
AstraZeneca
Phase 3
407
Bangalore, Bengaluru, Karamsad, Kolkata, Nashik, Vadodara
2018-11-27
Active, closed
AstraZeneca
Phase 3
730
Bengaluru, Gūrgaon
2018-09-27
Active, closed
McMaster University
Not applicable
5,000
Sītāpura, Bengaluru, Bangalore, Hyderabad
2015-10-21
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Jaipur, Hyderabad, Bangalore, Bengaluru, Chennai, Gūrgaon, Kochi, New Delhi
2012-01
Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
NCT02493478Failed or Difficult Intubation, Sequela, Intubation; Difficult, Intubation Complication
Children's Hospital of Philadelphia
Observational
150,000
Bengaluru, Bangalore
2010-03
Rows per page Showing 1–87 of 87
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 8 November 2026. https://priyalifescience.com/clinical-trials-india/city/bengaluru

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in India and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,120 studies in total at the last sync on 08 Nov 2026, 03:16 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 87 of those studies with a site in Bengaluru.

How many clinical trials are recruiting in Bengaluru?

43 of the 87 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:16 UTC sync. A further 4 have not yet opened recruitment, 37 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bengaluru), 87 studies
PhaseStudiesRecruitingShare
Phase 3502357.5%
Not applicable9510.3%
Phase 4839.2%
Observational768%
Phase 2728%
Phase 2/3434.6%
Phase 1212.3%

Most active sponsors

Lead sponsors with the most studies (Bengaluru)
Lead sponsorStudiesRecruiting
AstraZeneca91
Bristol-Myers Squibb95
Novo Nordisk A/S63
Janssen Research & Development, LLC52
Pfizer54
Sanofi51
University of Pittsburgh53
Eli Lilly and Company42
Bayer32
Boehringer Ingelheim33
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.